Generics 6

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ethosuximide manufacturers

6 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

6 products found

ethosuximide

Capsules 250 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Comments
Reference product : ZARONTIN (Pfizer)
Manufacturer #13666
This pharmaceutical company is ISO 9001:2015 certified and focuses on providing high-quality finished pharmaceutical products globally. They leverage a network of manufacturing partners to ensure the highest quality and efficiency. While they offer a comprehensive range of products, specific details about therapy areas, dosage forms, production lines (e.g., prescription medications, over-the-counter drugs), key regions, and product patents are not provided in the text.

Manufacturer usually replies in 1 days

ethosuximide

Oral solution 250 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #11548
This pharmaceutical company is a global leader in research, development, manufacturing, and regulatory support for a wide range of products. They offer end-to-end services, from initial product identification to commercialization, catering to the healthcare needs of over 29 countries across multiple regions including North America, Europe, Asia, and Africa. Their expertise spans various therapeutic areas such as anti-infectives, CNS disorders, gynecology, allergy treatment, erectile dysfunction, and gastrointestinal conditions. They utilize diverse dosage forms like oral solids, topicals, and liquids, with packaging options tailored to each product. The company holds significant GMP certifications from international regulatory bodies, ensuring the quality and safety of their products. Their dedicated team of scientists continuously drives innovation and development within their certified research facility.

Manufacturer usually replies in 8 days

ethosuximide

Capsules 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #31580

Established in 1990, this Indian manufacturer employs approximately 3,065 individuals and specializes in developing and manufacturing IP-led niche finished dosage formulations. As a CTD dossier owner and manufacturer, it holds GMP certifications from major regulatory authorities, including the US FDA, EU-GMP, Health Canada, and UK MHRA, ensuring compliance with stringent international quality standards. The company operates eight manufacturing units across India, Singapore, Italy, the United States, and Kenya, producing a range of products, including soft gelatin capsules, tablets, and ointments. As a CTD dossier owner and manufacturer, its products are distributed in over 100 countries worldwide.

Manufacturer usually replies in 2 days

Want to see all 6 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Ethosuximide

Ethosuximide is a medication used to treat absence seizures. It can be used as a standalone therapy or with other antiseizure medications like valproic acid. Ethosuximide is taken by mouth. It is approved for absence seizures. Ethosuximide is a drug of choice for treating absence seizures as it lacks the idiosyncratic hepatotoxicity of the valproic acid. Ethosuximide sold under the brand name Zarontin among others. Bayer Ag filed for the first patents and got them approved for medical use in the United States in 1960. Ethosuximide is listed on WHO's List of Essential Medicines and sold as a generic medication.

Dosage Forms & Strengths

Ethosuximide is available as a capsule in 250 mg strength and as a syrup in 250mg/5mL. In the treatment of Absence Seizures, the usual recommended dose is 500 a day which can be increased by 250 mg a day but generally not exceeding 1.5 g a day in total dose. In the Therapeutic range, the dose is between 40-100 mg/L and will need between 4-7 days to reach steady-state

The Price of Ethosuximide

In the USA, the consumers pay an average retail price of $256.30 for the supply of 120 capsules of a generic brand. However, the price of this medicine is significantly cheaper in the developing world, for example, the generic version of a bottle containing 50mg of this costs around USD 0.22.

How does Ethosuximide work?

Ethosuximide’s exact mechanism of action is not yet been entirely understood fully. However, it has been postulated that Ethosuximide work through a partial antagonism of T-type calcium channels of the thalamic neurons. The result of this antagonism is a decrease in burst firing of Thalamocortical neurons, all this cascading effect stabilizes the nerve activity in the brain resulting in the prevention of seizures.

Finding Ethosuximide Manufacturers and Suppliers

The best way to find and gain access to Ethosuximide manufacturers and Ethosuximide suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Ethosuximide can be a the time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Ethosuximide to work with. You can fine-tune your search results using various filters too, letting you search for Ethosuximide from specific countries.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible